A, T., DA, H., GD, P., & JM, D. (2021). Short Versus Extended Duration Vancomycin and Piperacillin/Tazobactam and the Incidence of Acute Kidney Injury in Noncritically Ill Patients. Journal of pharmacy practice, 34(6), 882. https://doi.org/10.1177/0897190020933488
Chicago Style (17th ed.) CitationA, Traversa, Hammond DA, Peksa GD, and DeMott JM. "Short Versus Extended Duration Vancomycin and Piperacillin/Tazobactam and the Incidence of Acute Kidney Injury in Noncritically Ill Patients." Journal of Pharmacy Practice 34, no. 6 (2021): 882. https://doi.org/10.1177/0897190020933488.
MLA (9th ed.) CitationA, Traversa, et al. "Short Versus Extended Duration Vancomycin and Piperacillin/Tazobactam and the Incidence of Acute Kidney Injury in Noncritically Ill Patients." Journal of Pharmacy Practice, vol. 34, no. 6, 2021, p. 882, https://doi.org/10.1177/0897190020933488.